Anaphylaxis
5 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| "Rush" regimen for anaphylaxis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| FMXIN002 double dose + FMXIN002 double dose + NAC + FMXIN002 single dose + FMXIN002 single dose + NAC + Epinephrine for anaphylaxis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Omalizumab for anaphylaxis | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Peanut for anaphylaxis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Peanut oral immunotherapy for anaphylaxis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |